As medicine advances toward more individualized care, clinical diagnostics are playing an increasingly vital role. Traditionally, diagnostic tests have been used to identify and classify diseases.

Strategic focus shifted from cautious spending and scaling to a full embrace of growth, especially with the 170% test volume growth target for 2026 and a doubling of sales reps. Guidance language ...

As we start a new year, the clinical diagnostics industry finds itself at the intersection of rapid technological progress and significant uncertainty. I anticipate that continued innovation amid this ...

The longevity industry has reached an inflection point. With companies like Function Health raising hundreds of millions in ...

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease.

Scientists at Queen Mary, University of London, have announced a new machine-learning-based method for predicting the biological therapy, or biologic, most likely to successfully relieve symptoms for ...

Neuropsychiatric disorders need new drugs that offer improvement in safety and efficacy over currently available medicines. Draig Therapeutics has emerged from stealth with $140 million to support mid ...

The Trump administration’s latest effort to lower drug costs is expanding to biosimilars, medications that are highly similar to biologic drugs made with or isolated from living organisms such as ...

Kymera Therapeutics has announced that Sanofi will advance their next-generation oral IRAK4 degrader, KT-485, into clinical testing, while opting not to pursue KT-474. Preclinical studies indicated ...

The most powerful engine driving the explosion of virtual ADHD and autism screenings is simply speed. In countless cities, locking down an in-person clinical appointment triggers agonizing delays.